|
1
|
Chang CC, Lee YC, Tsai HW, Yii SC, Yen TH
and Chu FY: Diagnostic role of serum free-to-total prostate
specific antigen (PSA) ratio in prostate cancer with serum total
concentration of PSA below 4 ng/ml. Asian Pac J Cancer Prev.
16:5261–5264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koo KC, Park SU, Kim KH, Rha KH, Hong SJ,
Yang SC and Chung BH: Predictors of survival in prostate cancer
patients with bone metastasis and extremely high prostate-specific
antigen levels. Prostate Int. 3:10–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh D, Febbo PG, Ross K, Jackson DG,
Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, et
al: Gene expression correlates of clinical prostate cancer
behavior. Cancer Cell. 1:203–209. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heestand GM and Kurzrock R: Molecular
landscape of pancreatic cancer: Implications for current clinical
trials. Oncotarget. 6:4553–4561. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khemlina G, Ikeda S and Kurzrock R:
Molecular landscape of prostate cancer: Implications for current
clinical trials. Cancer Treat Rev. 41:761–766. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Myers SM and Collins I: Recent findings
and future directions for interpolar mitotic kinesin inhibitors in
cancer therapy. Future Med Chem. 8:463–489. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Gong H and Huang K: Oncogenic role
of kinesin proteins and targeting kinesin therapy. Cancer Sci.
104:651–656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rath O and Kozielski F: Kinesins and
cancer. Nat Rev Cancer. 12:527–539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bernasconi P, Cappelletti C, Navone F,
Nessi V, Baggi F, Vernos I, Romaggi S, Confalonieri P, Mora M,
Morandi L and Mantegazza R: The kinesin superfamily motor protein
KIF4 is associated with immune cell activation in idiopathic
inflammatory myopathies. J Neuropathol Exp Neurol. 67:624–632.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu CK, Coughlin M, Field CM and Mitchison
TJ: KIF4 regulates midzone length during cytokinesis. Curr Biol.
21:815–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Samejima K, Samejima I, Vagnarelli P,
Ogawa H, Vargiu G, Kelly DA, de Lima Alves F, Kerr A, Green LC,
Hudson DF, et al: Mitotic chromosomes are compacted laterally by
KIF4 and condensin and axially by topoisomerase IIα. J Cell Biol.
199:755–770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurasawa Y, Earnshaw WC, Mochizuki Y,
Dohmae N and Todokoro K: Essential roles of KIF4 and its binding
partner PRC1 in organized central spindle midzone formation. EMBO
J. 23:3237–3248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mazumdar M, Sundareshan S and Misteli T:
Human chromokinesin KIF4A functions in chromosome condensation and
segregation. J Cell Biol. 166:613–620. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wordeman L: How kinesin motor proteins
drive mitotic spindle function: Lessons from molecular assays.
Semin Cell Dev Biol. 21:260–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oki E, Hisamatsu Y, Ando K, Saeki H,
Kakeji Y and Maehara Y: Clinical aspect and molecular mechanism of
DNA aneuploidy in gastric cancers. J Gastroenterol. 47:351–358.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Minakawa Y, Kasamatsu A, Koike H, Higo M,
Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H
and Uzawa K: Kinesin Family member 4A: A potential predictor for
progression of human oral cancer. PLoS One. 8:e859512013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taniwaki M, Takano A, Ishikawa N, Yasui W,
Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y and Daigo Y:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13:6624–6631. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Narayan G, Bourdon V, Chaganti S,
Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider
A, Pothuri B, et al: Gene dosage alterations revealed by cDNA
microarray analysis in cervical cancer: Identification of candidate
amplified and overexpressed genes. Genes Chromosomes Cancer.
46:373–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hou G, Dong C, Dong Z, Liu G, Xu H, Chen
L, Liu L, Wang H and Zhou W: Upregulate KIF4A enhances
proliferation, invasion of hepatocellular carcinoma and indicates
poor prognosis across human cancer types. Sci Rep. 7:41482017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Imai T, Oue N, Nishioka M, Mukai S, Oshima
T, Sakamoto N, Sentani K, Matsusaki K, Yoshida K and Yasui W:
Overexpression of KIF11 in gastric cancer with intestinal mucin
phenotype. Pathobiology. 84:16–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao J, Sai N, Wang C, Sheng X, Shao Q,
Zhou C, Shi Y, Sun S, Qu X and Zhu C: Overexpression of
chromokinesin KIF4 inhibits proliferation of human gastric
carcinoma cells both in vitro and in vivo. Tumour Biol. 32:53–61.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grasso CS, Wu YM, Robinson DR, Cao X,
Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC,
et al: The mutational landscape of lethal castration-resistant
prostate cancer. Nature. 487:239–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cancer Genome Atlas Research Network: The
molecular taxonomy of primary prostate cancer. Cell. 163:1011–1025.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu C and Jiang W: Cell cycle-dependent
translocation of PRC1 on the spindle by Kif4 is essential for
midzone formation and cytokinesis. Proc Natl Acad Sci USA.
102:343–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miki H, Okada Y and Hirokawa N: Analysis
of the kinesin superfamily: Insights into structure and function.
Trends Cell Biol. 15:467–476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miki H, Setou M, Kaneshiro K and Hirokawa
N: All Kinesin Superfamily Protein, KIF, Genes in Mouse and Human.
Proc Natl Acad Sci USA. 98:7004–7011. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Skolarus TA, Zhang Y, Miller DC, Wei JT
and Hollenbeck BK: The economic burden of prostate cancer
survivorship care. J Urol. 184:532–538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Esfahani M, Ataei N and Panjehpour M:
Biomarkers for evaluation of prostate cancer prognosis. Asian Pac J
Cancer Prev. 16:2601–2611. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Wang H, Huang C and Qian H:
Subcellular localization of MTA proteins in normal and cancer
cells. Cancer Metastasis Rev. 33:843–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu X, Zhou Y, Liu X, Peng A, Gong H,
Huang L, Ji K, Petersen RB, Zheng L and Huang K: MPHOSPH1: A
potential therapeutic target for hepatocellular carcinoma. Cancer
Res. 74:6623–6634. 2014. View Article : Google Scholar : PubMed/NCBI
|
